- What is Exagen Inc. Common Stock's Market Cap?
- Exagen Inc. Common Stock's Market Cap is $176.7M, based on as-reported figures from SEC (XBRL) filings.
- What is Exagen Inc. Common Stock's Enterprise Value?
- Exagen Inc. Common Stock's Enterprise Value is $177.7M, based on as-reported figures from SEC (XBRL) filings.
- What is Exagen Inc. Common Stock's Price / Sales?
- Exagen Inc. Common Stock's Price / Sales is 2.5×, based on as-reported figures from SEC (XBRL) filings.
- What is Exagen Inc. Common Stock's EV / Revenue?
- Exagen Inc. Common Stock's EV / Revenue is 2.5×, based on as-reported figures from SEC (XBRL) filings.
- What is Exagen Inc. Common Stock's EV / EBITDA?
- Exagen Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
- What is Exagen Inc. Common Stock's Revenue (TTM)?
- Exagen Inc. Common Stock's Revenue (TTM) is $71.1M, based on as-reported figures from SEC (XBRL) filings.
- What is Exagen Inc. Common Stock's Net Income (TTM)?
- Exagen Inc. Common Stock's Net Income (TTM) is -$18.9M, based on as-reported figures from SEC (XBRL) filings.
- What is Exagen Inc. Common Stock's EBITDA?
- Exagen Inc. Common Stock's EBITDA is -$10.8M, based on as-reported figures from SEC (XBRL) filings.
- What is Exagen Inc. Common Stock's Diluted EPS (TTM)?
- Exagen Inc. Common Stock's Diluted EPS (TTM) is -0.78, based on as-reported figures from SEC (XBRL) filings.
- What is Exagen Inc. Common Stock's EBITDA Margin?
- Exagen Inc. Common Stock's EBITDA Margin is -15.2%, based on as-reported figures from SEC (XBRL) filings.